Every year, Google’s Pixel keynote is dominated by flashy AI demos and magic camera tricks that promise to rewrite your ...
The decision arrives months after its iOS and Android launch.
Replimune (REPL) stock plunges as the company seeks layoffs following the FDA rejection of its cancer drug RP1 for melanoma.